Catalog No.
DVV00502
Expression system
Mammalian Cells
Species reactivity
SARS-CoV-2(2019-nCoV)
Host species
Human
Isotype
IgG1
Clonality
Monoclonal
Target
Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P0DTC2
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
CV3-25
Structure and inhibition of SARS-CoV-2 spike refolding in membranes., PMID:39146425
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD., PMID:36514310
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit., PMID:35411021
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses., PMID:35216664
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection., PMID:35123652
SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells., PMID:35062211
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern., PMID:34971573
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern., PMID:34373853
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects., PMID:34237283
Magnitude and reliability of mechanical outputs obtained during loaded squat jumps performed from different knee angles., PMID:31232220